By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Abbott today reported that its molecular diagnostics sales for the first quarter of 2011 grew around 14 percent year over year.

The Abbott Park, Ill.-based maker of medical diagnostics and devices, pharmaceuticals, and nutritional products, said that its molecular diagnostics products brought in revenue of $99 million for the quarter. Of that total, $45 million came from the US market and the rest from international markets.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: mtDNA analysis give glimpse into decline of Neanderthals in Europe, and more.

The University of Arizona's Raina Maier writes that an understanding of the Earth's microbiome is needed.

The proposed Canadian budget emphasizes partnerships with industry, Nature News reports.

An Australian study of personalized medicine has run into problems as it recruits patients.